These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 17934705)

  • 1. [Elderly patients in clinical trials: new fitness-adapted concepts].
    Goede V; Hallek M
    Internist (Berl); 2007 Nov; 48(11):1232-7. PubMed ID: 17934705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic potential of new B cell-targeted agents in the treatment of elderly and unfit patients with chronic lymphocytic leukemia.
    Rai KR
    J Hematol Oncol; 2015 Jul; 8():85. PubMed ID: 26170206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of elderly patients with chronic lymphocytic leukemia in the era of targeted therapies.
    Ysebaert L; Feugier P; Michallet AS
    Curr Opin Oncol; 2015 Sep; 27(5):365-70. PubMed ID: 26154708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of elderly and unfit patients with chronic lymphocytic leukemia.
    Mauro FR; Salaroli A; Caputo MD; Colafigli G; Petrucci L; Campanelli M; Ferretti A; Guarini AR; Foà R
    Expert Rev Hematol; 2016 Dec; 9(12):1165-1175. PubMed ID: 27796157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating oncogeriatric tools into the management of chronic lymphocytic leukemia: current state of the art and challenges for the future.
    Merli F; Mammi C; Ilariucci F
    Curr Oncol Rep; 2015 Jul; 17(7):31. PubMed ID: 25986721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obinutuzumab treatment in the elderly patient with chronic lymphocytic leukemia.
    Seiter K; Mamorska-Dyga A
    Clin Interv Aging; 2015; 10():951-61. PubMed ID: 26109852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Shifting Paradigm in Chronic Lymphocytic Leukemia: Is Chemotherapy Still Relevant?
    Jain N; OʼBrien S
    Cancer J; 2019; 25(6):374-377. PubMed ID: 31764117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What Is Optimal Front-Line Therapy for Chronic Lymphocytic Leukemia in 2017?
    Voorhies BN; Stephens DM
    Curr Treat Options Oncol; 2017 Feb; 18(2):12. PubMed ID: 28243993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GERiatric Screening in the treatment of elderly patients with Ovarian Carcinoma (GERSOC): study protocol for a pragmatic, cluster randomised controlled trial.
    van Soolingen NJ; Smorenburg CH; Hamaker ME; Groen WG; Retèl VP; Lok CAR; van de Poll-Franse LV; Trum JW
    Trials; 2020 Feb; 21(1):214. PubMed ID: 32087750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New treatment approaches in CLL: Challenges and opportunities in the elderly.
    Eichhorst B; Hallek M; Goede V
    J Geriatr Oncol; 2016 Sep; 7(5):375-82. PubMed ID: 27491497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).
    Lund CM; Vistisen KK; Dehlendorff C; Rønholt F; Johansen JS; Nielsen DL
    BMC Cancer; 2017 Jun; 17(1):448. PubMed ID: 28659138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A network meta-analysis of progression free survival and overall survival in first-line treatment of chronic lymphocytic leukemia.
    Ladyzynski P; Molik M; Foltynski P
    Cancer Treat Rev; 2015 Feb; 41(2):77-93. PubMed ID: 25512118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HOVON68 CLL trial revisited: performance status and comorbidity affect survival in elderly patients with chronic lymphocytic leukemia.
    Vojdeman FJ; Van't Veer MB; Tjønnfjord GE; Itälä-Remes M; Kimby E; Polliack A; Wu KL; Doorduijn JK; Alemayehu WG; Wittebol S; Kozak T; Walewski J; Abrahamse-Testroote MC; van Oers MH; Geisler CH
    Leuk Lymphoma; 2017 Mar; 58(3):594-600. PubMed ID: 27484290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic lymphocytic leukemia: current standards and novel approaches].
    Tausch E; Stilgenbauer S
    Internist (Berl); 2014 Dec; 55(12):1400, 1402-4, 1406-9. PubMed ID: 25392275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First immunochemotherapy outcomes in elderly patients with CLL: a retrospective analysis.
    Michallet AS; Cazin B; Bouvet E; Oberic L; Schlaifer D; Mosser L; Salles G; Coiffier B; Laurent G; Ysebaert L
    J Geriatr Oncol; 2013 Apr; 4(2):141-7. PubMed ID: 24071539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer.
    Anido-Herranz U; Fernández-Núñez N; Afonso-Afonso J; Santomé-Couto L; Medina-Colmenero A; Fernández-Calvo O; Lázaro-Quintela M; Vázquez S
    Clin Transl Oncol; 2019 Mar; 21(3):249-258. PubMed ID: 30051212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How I treat elderly or comorbid patients with chronic lymphocytic leukemia.
    Smolej L
    Acta Medica (Hradec Kralove); 2010; 53(4):213-20. PubMed ID: 21400979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Definition of Unfit for Standard Acute Myeloid Leukemia Therapy.
    Klepin HD
    Curr Hematol Malig Rep; 2016 Dec; 11(6):537-544. PubMed ID: 27681539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of primary and advanced breast cancer in older unfit patients (medical treatment).
    Aapro M; Monfardini S; Jirillo A; Basso U
    Cancer Treat Rev; 2009 Oct; 35(6):503-8. PubMed ID: 19762156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the treatment of elderly/unfit chronic lymphocytic leukemia patients: results of the German CLL-11 trial.
    Molica S
    Expert Rev Anticancer Ther; 2015 Jan; 15(1):9-15. PubMed ID: 25479582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.